-
Healthcare Costs Associated With Adverse Events During Treatment Episodes for Pediatric Attention-Deficit/Hyperactivity Disorder
Mar 10, 2025, 14:00 PM -
LEGION Revision Knee System Using Oxidized Zirconium Technology Improves Short-Term Clinical Outcomes and Reduces Re-revision Rates: Insights from a Large US Claims Database
Mar 10, 2025, 14:00 PM -
Absenteeism and Presenteeism Associated With Chronic Conditions in a Canadian Working Population
Mar 10, 2025, 14:00 PM -
Comparing Predicted vs. Real-World Spending in the United States for Single-Administration Cell and Gene Therapies
Mar 10, 2025, 14:00 PM -
Economic and Healthcare Burden in Patients with Sjögren's Syndrome: A Systematic Review
Mar 10, 2025, 14:00 PM -
Utilization of Overall Survival and Other Survival Endpoints in Clinical Trials for Adjuvant Therapies in Resectable Tumors
Mar 10, 2025, 14:00 PM -
Cost-Minimization: Consequences of Using the Lowest Cost Comparator Over the Weighted Average Cost (WAC)
Mar 10, 2025, 14:00 PM -
Humanistic Burden in Metastatic Triple-Negative Breast Cancer (mTNBC): A Systematic Literature Review (SLR)
Mar 10, 2025, 14:00 PM -
Spillover Effects of Medical Innovations: A Generic and Scalable Approach to Measure the Societal Value of Avoided Informal Care Time
Mar 10, 2025, 14:00 PM -
Emerging Trends in List Price Adjustment Strategies Following Implementation of the Inflation Reduction Act
Mar 10, 2025, 14:00 PM -
A Descriptive Analysis of Demographic, Co-Morbid and Prescribing Data from the UK CPRD in People with Type 2 Diabetes and Cardiovascular Conditions
Mar 10, 2025, 14:00 PM -
Incorporating Social Drivers of Health Information Into Health Economics and Outcomes Research: Neighborhood-Level Proxies Versus Individual Level Data
Mar 10, 2025, 14:00 PM -
A Case-Study on the Implementation of the Population Health Agreement for Inclisiran in England
Mar 10, 2025, 14:00 PM -
Validation of a Questionnaire to Evaluate Simplicity of Diabetes Treatment (SIM-Q)
Mar 10, 2025, 14:00 PM -
Treatment Patterns, Clinical Outcomes, Healthcare Resource Utilization, and Healthcare Costs Among Patients With Metastatic Gastric/Gastroesophageal Junction Cancer in Medicare Beneficiaries
Mar 10, 2025, 14:00 PM -
Assessing the Impact of Exagamglogene Autotemcel (Exa-cel) on Health Inequalities in Patients with Sickle Cell Disease in the United Kingdom and Canada
Mar 10, 2025, 14:00 PM -
What Non-Profit Development of Pretomanid Can Teach About Paths to Innovation and Global Access to Treatments for Diseases of Poverty?
Mar 10, 2025, 14:00 PM -
Precision Medicine Enabled Benefits Management for Oral Diabetes and Weight Loss Management
Mar 10, 2025, 14:00 PM -
Recurrent Patient-Reported Outcome (PRO)-Based Symptomatic Deterioration Predicts Survival and Disease Progression in Patients With Resectable Non-Small Cell Lung Cancer (NSCLC): Post-Hoc Analysis of RATIONALE-315
Mar 10, 2025, 14:00 PM -
Cost-effectiveness of Chimeric Antigen Receptor (CAR) T-cell Therapy for Relapsed or Refractory Large B-cell Lymphoma (r/r LBCL): A Systematic Review and Meta-Analysis
Mar 10, 2025, 14:00 PM
